Boulder-based Ambrosia Biosciences secured $100 million in oversubscribed Series B funding to advance its oral small molecule GLP-1 through clinical trials, led by Blue Owl, Redmile, and Deep Track Capital.
JPMorgan: Crypto Market Structure Act likely to pass mid-year
JPMorgan predicts the Crypto Market Structure Act will likely pass by mid-2026, potentially transforming the crypto market and attracting institutional investors.
Get full access to view complete information
1 - 1 of 1
Get full access to view complete information
Frequently Asked Questions Regarding Redmile Ltd
Company Overview
1999
Founded
Others
Industry
United Kingdom
Location
805,080,801
Ranking
0 employees
Size
Similar Companies
Get full access to view complete information
Frequently Asked Questions Regarding Redmile Ltd
Start your journey today
Start with the platform — or start with a conversation
Use Pubrio on your own, or let our team help you with research, lead generation, or data integration.